+97.1%
GSK vs RVTY
+198.4%
-101.4%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | RVTY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -4.2% | +4.1% | +0.6% |
| 7D | -5.3% | -5.9% | +0.6% | -4.3% |
| 30D | -3.7% | -7.2% | +3.6% | -2.6% |
| 3M | -7.3% | +17.0% | -24.3% | -10.5% |
| 6M | -4.2% | +53.3% | -57.6% | -12.5% |
| YTD | +0.9% | +50.5% | -49.6% | -8.2% |
| 1Y | +7.3% | +54.8% | -47.6% | -3.0% |
| 3Y | +52.7% | +66.1% | -13.4% | +33.6% |
| 5Y | +40.1% | -22.2% | +62.3% | +41.4% |
| All | +97.1% | +198.4% | -101.4% | +39.9% |
Cumulative growth
Daily Returns
Daily percentage return beside RVTY.
Daily Out/Under-Performance
Portfolio return minus RVTY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RVTY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded RVTY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling